Publication | Open Access
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study
38
Citations
18
References
2023
Year
VPZ with b.i.d. or t.i.d. amoxicillin for 14 days provides satisfactory efficacy as a first-line treatment for <i>H. pylori</i> infection in China.
| Year | Citations | |
|---|---|---|
Page 1
Page 1